Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/18/2003EP1319073A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
06/18/2003EP1319072A2 G-protein coupled receptor hfrbn63
06/18/2003EP1319071A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/18/2003EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/18/2003EP1319067A2 Human coagulation factor vii variants
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319063A1 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319023A2 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof
06/18/2003EP1319022A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
06/18/2003EP1319015A2 Olfactory and pheromones g-protein coupled receptors
06/18/2003EP1318840A2 PHOSPHATONIN-RELATED GENE AND i METHODS OF USE THEREOF /i
06/18/2003EP1318833A2 Compositions and methods for cell dedifferentiation and tissue regeneration
06/18/2003EP1232247A4 Modulation of signal transduction
06/18/2003EP1181306A4 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
06/18/2003EP1171578B1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
06/18/2003EP1032428B1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/18/2003EP0891427B1 Expression of hgv antigens and their use
06/18/2003EP0821739B1 An adenovirus helper-virus system
06/18/2003EP0650377B1 Neuroinhibitory compounds released by implanting devices
06/18/2003EP0538404B1 Fibroblast growth factor receptors
06/18/2003CN1425136A Assay of isomerised and/or optically inverted proteins and protein fragments
06/18/2003CN1425070A Rice-origin gibberellin 2 & š�-hydroxylase genes and utilization thereof
06/18/2003CN1425068A Fungal transcriptional activator useful in methods for producing polypeptides
06/18/2003CN1425066A Novel stra6 polypeptides
06/18/2003CN1425064A Embryonic or stem-like cells produced by cross species nuclear transplantation
06/18/2003CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene
06/18/2003CN1425061A Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
06/18/2003CN1425027A HCV non-structural polypeptide
06/18/2003CN1425023A Transgenic mice containing TRP gene disruptions
06/18/2003CN1424873A Method of cryopreserving selected sperm cells
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1424396A Preparation of implanting neurons for treating nerve injury diseases
06/18/2003CN1424395A Snow lotus cell series with stable high productive flavone for mass plant cell culture and its establishing method
06/18/2003CN1424394A Method for establishing human stem cells series
06/17/2003US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use
06/17/2003US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist
06/17/2003US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes.
06/17/2003US6579969 Purified polypeptide of given amino acid sequence; serine/threonine kinase
06/17/2003US6579841 Variant EGIII-like cellulase compositions
06/17/2003US6579716 Better emergence characteristics and improved seedling growth under low-light environments
06/17/2003US6579710 Human kinases and polynucleotides encoding the same
06/17/2003US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/17/2003US6579700 Neuropeptide Y (NPY); isolated peptide of given amino acid sequence; may be useful in regulating central and peripheral nervous and endocrine systems
06/17/2003US6579688 Stabilizing diluent for polypeptides and antigens
06/17/2003US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins
06/17/2003US6579676 A population of recombinant cells comprising mutant cDNAs; encode a particular protein which comprises binding domains having different ligands; useful in design of new ligands and drugs
06/17/2003US6579523 Transplants for myocardial scars
06/17/2003US6579522 Replication deficient adenoviral TNF vector
06/17/2003US6579520 IL-17 related mammalian cytokine polypeptides (IL-17E)
06/17/2003US6579313 Methods for implanting cells
06/17/2003US6579256 Instrument for subretinal implantation
06/17/2003CA2118816C Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/17/2003CA2072249C Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
06/17/2003CA1341432C Variants of plasminogen activators and processes for their production
06/12/2003WO2003048735A2 Processes for the measurement of the potency of glatiramer acetate
06/12/2003WO2003048731A2 Antibody categorization based on binding characteristics
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048375A1 Hybrid glycosylated products and their production and use
06/12/2003WO2003048370A1 Method for screening molecules modulating gene expression, cell lines, preparation and uses
06/12/2003WO2003048364A2 Ovomucoid promoter and methods of use
06/12/2003WO2003048349A2 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
06/12/2003WO2003048348A2 Production of viruses, viral isolates and vaccines
06/12/2003WO2003048346A1 Gene targeting methods and vectors
06/12/2003WO2003048345A1 Phenotypic screen of chimeric proteins
06/12/2003WO2003048344A2 Differentiation of human embryonic stem cells in avian embryos
06/12/2003WO2003048337A2 Antibody to latent membrane proteins and uses thereof
06/12/2003WO2003048336A2 Cultured cells from pancreatic islets
06/12/2003WO2003048329A2 Chromosomal saturation mutagenesis
06/12/2003WO2003048313A2 Cell culture media
06/12/2003WO2003048310A2 Thermus oshimai nucleic acid polymerases
06/12/2003WO2003048309A2 Thermus thermophilus nucleic acid polymerases
06/12/2003WO2003048306A2 Polycistronic expression of antibodies
06/12/2003WO2003048209A1 Bispecific anti-cd19 x anti-cd16 antibodies and uses thereof
06/12/2003WO2003048208A2 Expression control using variable intergenic sequences
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048197A1 Production and of viruses, viral isolates and vaccines
06/12/2003WO2003048193A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
06/12/2003WO2003048184A2 Flavivirus ns1 subunit vaccine
06/12/2003WO2003047647A1 Method for forming matrices of hardened material
06/12/2003WO2003047635A1 Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders
06/12/2003WO2003047611A2 Ptp10d, tec and edtp involved in triglycerid-metabolism
06/12/2003WO2003047606A2 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
06/12/2003WO2003047532A2 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
06/12/2003WO2003047527A2 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
06/12/2003WO2003047507A2 Factor viii c2 domain variants
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003WO2003047421A2 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003WO2003047420A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
06/12/2003WO2003047336A2 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES
06/12/2003WO2003047331A2 Methods and apparatus for cell based screening
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2003018829A3 6299, a human zinc carboxypeptidase family member and uses therefor
06/12/2003WO2003018752A3 An organotypic intestinal culture and methods of use thereof
06/12/2003WO2003016860A3 Systems and methods for screening pharmaceutical chemicals
06/12/2003WO2002103031A3 Methods for detecting and treating the early onset of aging-related conditions
06/12/2003WO2002068627A3 Vector constucts
06/12/2003WO2002057465A3 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 1827